covid 19 News and Research

RSS

Researchers investigate link between COVID-19 and increased risk of blood clot formation

People who have recovered from COVID-19, especially those with pre-existing cardiovascular conditions, may be at risk of developing blood clots due to a lingering and overactive immune response, according to a study led by Nanyang Technological University, Singapore (NTU) scientists.

13 Apr 2021

Clinical trial of monoclonal antibody for treating respiratory disease in COVID-19 patients begins

A clinical trial testing the safety and efficacy of an investigational monoclonal antibody for treating people who are hospitalized with respiratory disease and low blood oxygen due to infection with SARS-CoV-2, the virus that causes COVID-19, has begun.

13 Apr 2021

New research could change how doctors treat some patients with high blood pressure

New research led by a professor at NUI Galway is set to change how doctors treat some patients with high blood pressure - a condition that affects more than one in four men and one in five women.

13 Apr 2021

Study finds higher death rates among UK cancer patients following COVID-19 diagnosis

Cancer patients from the UK were 1.5 times more likely to die following a diagnosis with COVID-19 than cancer patients from European countries.

13 Apr 2021

Could cow's milk provide some passive immunity against COVID-19?

Researchers at the Department of Animal Health, University of Cordoba, Córdoba, Spain, speculate that bovine milk consumption – specifically from cows with resistance to bovine coronaviruses – may potentially provide at least some degree of protection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The article is available to read in full on the Frontiers in Immunology website.

13 Apr 2021

Albumedix Expands Production Capacity at its Commercial-Scale Recombinant Human Albumin Manufacturing Plant and Opens New Research Facilities

Albumedix Ltd. ('Albumedix'), a recognized global leader in recombinant human albumin specializing in the enablement of advanced therapies, announces the completed expansion of the company’s commercial-scale manufacturing facility, alongside with the establishment of a new Technology Centre equipped with state-of-the-art laboratories at its UK-based campus in Nottingham.

From Albumedix Ltd. 13 Apr 2021

Scanning & Decoding Tube Racks Direct from Low Temperature Storage

Ziath has posted a new video that provides an easy-to-follow guide to assist scientists and technicians scanning and decoding sample tube racks direct from low temperature storage

From Ziath Ltd 13 Apr 2021

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

In a recent bioRxiv* preprint, the large team of researchers evaluated a SARS-CoV-2 Spike receptor-binding domain ferritin nanoparticle protein vaccine (RFN) in a nonhuman primate challenge model. This study addresses the need for a next-generation, efficacious vaccine with an increased pan-SARS breadth of coverage.

13 Apr 2021

Researchers identify SARS-CoV-2 antiviral compounds using protein assay

During the process of SARS-CoV-2 infection, once the virus penetrates the host cell, two open reading frames, ORF1a and ORF1ab, are translated. ORF1ab is responsible for the production of 16 nonstructural proteins (nsp). Several viral proteases such as 3CLpro and PLpro (papain-like protease) produce 1-16 nsps. A new study has been published in bioRxiv* preprint server, which deals with identifying drugs that are effective as PLpro inhibitors.

13 Apr 2021

Measurable antibody response to mRNA COVID-19 vaccine in elderly care home residents

A new preprint research paper posted to the medRxiv* server explores the antibody response to COVID-19 vaccines in elderly residents of nursing homes in the USA. As of March 2021, there have been over 1.4 million infections from SARS-CoV-2 and over 175,000 deaths related to the pandemic among nursing home residents in the country.

13 Apr 2021

ACE2 homology in laboratory and wild animals

A new preprint research paper posted to the bioRxiv server describes the conservation of an important receptor gene for the virus among several animal species that live in close contact or proximity to humans.

13 Apr 2021

Zipper motif mediates SARS-CoV-2 spike trimerization within host cell membrane

A new preprint research paper posted to the bioRxiv* server describes the results of a nuclear magnetic resonance (NMR) study to determine the structure of the S protein transmembrane domain (TMD) and its membrane-proximal regions.

13 Apr 2021

SARS-CoV-2 viable 21 days in blood, mucus, semen, urine, but just 24 hours in breast milk

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), spreads through respiratory droplets and aerosols expelled when infected individuals cough, sneeze, breathe or sing.

13 Apr 2021

PCR-based reverse genetic system helps analyze SARS-CoV-2 mutations

SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. We know that mutations in the genome of SARS-CoV-2 have occurred and spread, but what effect do those mutations have?

13 Apr 2021

Monitoring CO2 to assess risk of indoor airborne SARS-CoV-2 transmission

In the study, which appeared on the pre-print server medRxiv, the team developed a general mathematical theory to predict airborne transmission risk from carbon dioxide (CO2) time series in real-time and clarify different estimates that steer the guideline. The study findings were based on the assessment of transmission risk and implementing the guideline by CO2 monitoring in university classrooms and office spaces.

13 Apr 2021

Pandemic has triggered changes in mental health and physical activity

New research from McMaster University suggests the pandemic has created a paradox where mental health has become both a motivator for and a barrier to physical activity.

13 Apr 2021

CityMD experience during the coronavirus pandemic in New York City

Limiting SARS-CoV-2 transmission requires an infected person to quarantine themselves for at least two weeks. New research published on the medRxiv* server highlights the vital role urgent care centers play during the COVID-19 pandemic in New York.

13 Apr 2021

Inhibition of nsp14 methyltransferase as a potential antiviral target for SARS-CoV-2

Beyond vaccination, the broad-spectrum antiviral medication remdesivir has robust clinical evidence and is known as the best antiviral treatment to reduce severe COVID-19 infection in hospitalized patients. Research led by John F.X. Diffley of the Chromosome Replication Laboratory suggests a potential therapeutic target for treatment development is the viral RNA cap methyltransferases, essential for viral protein translation and immune evasion.

13 Apr 2021

Could Zebrafish larvae be a novel animal model for SARS-CoV-2?

Researchers based in Paris, France, have explored the potential use of zebrafish larvae as animal models for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These larvae are small and cheap, so could prove a suitable medium for rapid mass testing of the disease.

13 Apr 2021

Americans are consuming poor nutritional quality food everywhere, except at school

Whether eating out or buying food from the grocery store, Americans of all ages are, for the most part, eating poorly everywhere - except at school.

13 Apr 2021

covid 19 News and Research

Researchers investigate link between COVID-19 and increased risk of blood clot formation

Clinical trial of monoclonal antibody for treating respiratory disease in COVID-19 patients begins

New research could change how doctors treat some patients with high blood pressure

Study finds higher death rates among UK cancer patients following COVID-19 diagnosis

Could cow's milk provide some passive immunity against COVID-19?

Albumedix Expands Production Capacity at its Commercial-Scale Recombinant Human Albumin Manufacturing Plant and Opens New Research Facilities

Scanning & Decoding Tube Racks Direct from Low Temperature Storage

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

Researchers identify SARS-CoV-2 antiviral compounds using protein assay

Measurable antibody response to mRNA COVID-19 vaccine in elderly care home residents

ACE2 homology in laboratory and wild animals

Zipper motif mediates SARS-CoV-2 spike trimerization within host cell membrane

SARS-CoV-2 viable 21 days in blood, mucus, semen, urine, but just 24 hours in breast milk

PCR-based reverse genetic system helps analyze SARS-CoV-2 mutations

Monitoring CO2 to assess risk of indoor airborne SARS-CoV-2 transmission

Pandemic has triggered changes in mental health and physical activity

CityMD experience during the coronavirus pandemic in New York City

Inhibition of nsp14 methyltransferase as a potential antiviral target for SARS-CoV-2

Could Zebrafish larvae be a novel animal model for SARS-CoV-2?

Americans are consuming poor nutritional quality food everywhere, except at school

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News